An Open Label, Multi-centre, Non-interventional Post-marketing Surveillance to Monitor the Safety and/or Efficacy of AVANDAMET Between June 2004 and January 2010

CompletedOBSERVATIONAL

Enrollment

717

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Administration of rosiglitazone/metformin

Subjects who are administered rosiglitazone/metformin at least once